[Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training]

Camillo Taglieri1, Enrico Lombardo, Mauro Feola

  • 1Riabilitazione Cardiologica, Ospedale SS Trinità Fossano, Italy.

Insights

Preventing cardiac remodelling after myocardial infarction is crucial for patient prognosis. Therapies like ACE-inhibitors, beta-blockers, and aerobic training show efficacy in improving heart function and reducing adverse remodelling.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Science

Context:

  • Post-myocardial infarction (MI) left ventricular (LV) remodelling significantly impacts prognosis.
  • Therapies aim to prevent the progression of LV dysfunction to refractory heart failure post-MI.

Purpose:

  • To review therapeutic strategies for preventing post-MI cardiac remodelling.
  • To evaluate the efficacy of various treatments, including pharmacological agents and exercise interventions.

Summary:

  • ACE-inhibitors and beta-blockers are proven effective in managing post-MI remodelling.
  • Angiotensin receptor blockers (ARBs) like losartan and valsartan show comparable safety and efficacy to ACE-inhibitors.
  • Spironolactone offers benefits but carries a risk of hyperkalemia.
  • Aerobic physical training enhances left ventricular ejection fraction and reduces LV enlargement post-MI, potentially via neurohormonal, microcirculatory, and endothelial improvements.

Impact:

  • Effective management of post-MI remodelling can improve patient outcomes and reduce heart failure progression.
  • Aerobic training presents a non-pharmacological approach to mitigate adverse cardiac remodelling.
  • Understanding these therapeutic targets is vital for optimizing patient care following acute myocardial infarction.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...